Drug Price Trends for NDC 00591-5321

Average Pharmacy Cost for 00591-5321

Drug Name	NDC	Price/Unit ($)	Unit	Date
PRIMIDONE 250 MG TABLET	00591-5321-01	0.25079	EACH	2025-04-23
PRIMIDONE 250 MG TABLET	00591-5321-01	0.25368	EACH	2025-03-19
PRIMIDONE 250 MG TABLET	00591-5321-01	0.23843	EACH	2025-02-19
PRIMIDONE 250 MG TABLET	00591-5321-01	0.22202	EACH	2025-01-22

Best Wholesale Price for NDC 00591-5321

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
No data available in table

Market Analysis and Price Projections for NDC 00591-5321: Primidone

In the ever-evolving landscape of pharmaceuticals, understanding market trends and price projections for specific drugs is crucial for healthcare providers, insurers, and patients alike. Today, we'll dive deep into the market analysis and price projections for the drug identified by National Drug Code (NDC) 00591-5321, which corresponds to Primidone, an anticonvulsant medication used to treat various types of seizures.

Understanding Primidone and Its Market Position

Primidone, marketed under the NDC 00591-5321, is an oral tablet produced by Actavis Pharma, Inc[9]. As an anticonvulsant, it plays a vital role in managing epilepsy and other seizure disorders. To fully grasp its market position, we need to consider several factors, including its current pricing, market demand, and competitive landscape.

Current Pricing and Market Demand

While specific pricing data for Primidone (NDC 00591-5321) isn't directly available in our search results, we can draw insights from general pharmaceutical pricing trends. The pharmaceutical industry is experiencing modest but stable revenue growth, with an estimated overall drug price inflation rate of 3.81% for 2025[6].

"Many hospitals around the country experienced a challenging 2023, including drug shortages and rising drug costs," said Carina Dolan, associate vice president, clinical oncology, pharmacoeconomics and market insights, Vizient[8].

This statement underscores the importance of managing pharmacy expenditures and strengthening the supply chain, which directly impacts drugs like Primidone.

Factors Influencing Price Projections

Several key factors will influence the price projections for Primidone (NDC 00591-5321) in the coming years:

1. Market Competition

The generic drug market, which includes Primidone, is highly competitive. This competition typically leads to price erosion over time. Industry experts predict an annual price erosion of around 3-5% for generic drugs due to market competition and regulatory pressures[4].

2. Regulatory Environment

The regulatory landscape plays a crucial role in drug pricing. FDA regulations and potential policy changes can significantly impact pricing strategies. Companies must comply with FDA regulations to maintain market presence and avoid penalties[2].

3. Economic Conditions

Broader economic factors, including inflation and healthcare spending, will continue to influence drug prices. The pharmaceutical industry is not immune to these macroeconomic trends.

4. Technological Advancements

Advancements in manufacturing processes and supply chain optimization can potentially reduce production costs, which may influence pricing strategies.

Price Projections for Primidone (NDC 00591-5321)

Based on the available data and industry trends, we can make the following projections for Primidone (NDC 00591-5321):

Short-term Projections (2025-2026)

Given the projected overall drug price inflation rate of 3.81% for 2025[6], we might expect a similar increase for Primidone. However, as a generic drug, it may experience less dramatic price changes.

Medium-term Projections (2027-2029)

In the medium term, the price of Primidone is likely to stabilize or potentially decrease due to market competition. The annual price erosion of 3-5% typical for generic drugs may come into play during this period[4].

Long-term Projections (2030 and beyond)

Long-term projections are more uncertain due to potential technological advancements, policy changes, and market dynamics. However, the trend of price erosion for generic drugs is likely to continue, barring any significant disruptions in the market.

Impact of Industry Trends on Primidone Pricing

Several broader industry trends will likely influence the pricing of Primidone (NDC 00591-5321) in the coming years:

1. Shift Towards Value-Based Healthcare

The industry-wide move towards value-based healthcare could impact pricing strategies for drugs like Primidone. This shift emphasizes the importance of demonstrating the drug's efficacy and value proposition.

2. Increased Focus on Rare Diseases

While Primidone is not a treatment for a rare disease, the industry's increased focus on rare diseases and specialty pharmaceuticals could indirectly impact pricing strategies for more common medications.

3. Advancements in AI and Data Analytics

The pharmaceutical industry is increasingly leveraging AI and data analytics to optimize various aspects of their operations, including pricing strategies. As one industry expert notes:

"More than 85% of biopharma executives we surveyed say they are investing in data, AI and digital tools in 2025 to build supply chain resiliency."[7]

These technological advancements could lead to more sophisticated and dynamic pricing models in the future.

Supply Chain Considerations

Supply chain dynamics play a crucial role in drug pricing and availability. For Primidone (NDC 00591-5321), several factors are worth considering:

1. Raw Material Availability

The availability and cost of raw materials needed to produce Primidone can significantly impact its pricing. Any disruptions in the supply chain for these materials could lead to price fluctuations.

2. Manufacturing Efficiency

Improvements in manufacturing processes could potentially reduce production costs, which might translate to more stable or even reduced prices for Primidone.

3. Distribution Networks

The efficiency of distribution networks can impact the final cost of Primidone to healthcare providers and patients. Optimizing these networks could potentially lead to cost savings.

Competitive Landscape

Understanding the competitive landscape is crucial for projecting the future pricing of Primidone (NDC 00591-5321):

1. Generic Competitors

As a generic drug, Primidone faces competition from other manufacturers producing the same active ingredient. This competition typically leads to price erosion over time.

2. Alternative Treatments

The development and market entry of new anticonvulsant medications could impact the demand for Primidone, potentially influencing its pricing.

3. Market Share Dynamics

Changes in market share among different manufacturers of Primidone could lead to pricing adjustments as companies compete for market dominance.

Regulatory Considerations

The regulatory environment plays a significant role in shaping the pharmaceutical market and influencing drug prices:

1. FDA Regulations

Compliance with FDA regulations is crucial for maintaining market presence. Any changes in these regulations could impact the production and pricing of Primidone.

2. Price Transparency Initiatives

Increasing pressure for drug price transparency could influence pricing strategies across the pharmaceutical industry, including for drugs like Primidone.

3. Policy Changes

Potential changes in healthcare policy, such as reforms to drug pricing legislation, could have significant impacts on the pricing of generic drugs like Primidone.

Patient Access and Affordability

Ensuring patient access and affordability is a key consideration in drug pricing:

1. Insurance Coverage

The extent of insurance coverage for Primidone can significantly impact patient out-of-pocket costs and overall demand for the drug.

2. Patient Assistance Programs

The availability and scope of patient assistance programs can influence the effective price of Primidone for many patients.

3. Generic Drug Policies

Any changes in policies related to generic drugs could have direct implications for the pricing and availability of Primidone.

Future Market Dynamics

Looking ahead, several factors could shape the future market for Primidone (NDC 00591-5321):

1. Technological Innovations

Advancements in drug delivery systems or formulations could potentially lead to new versions of Primidone, impacting the market for the current formulation.

2. Changing Treatment Paradigms

Evolving approaches to treating seizure disorders could influence the demand for Primidone and, consequently, its pricing.

3. Global Market Expansion

Expansion into new global markets could potentially impact the overall pricing strategy for Primidone.

Key Takeaways

1. The pharmaceutical industry is projecting an overall drug price inflation rate of 3.81% for 2025, which could influence Primidone pricing.

2. As a generic drug, Primidone (NDC 00591-5321) is likely to experience annual price erosion of 3-5% due to market competition.

3. Technological advancements, particularly in AI and data analytics, are shaping pricing strategies and supply chain management in the pharmaceutical industry.

4. Regulatory changes and policy shifts could significantly impact the pricing and market dynamics for Primidone.

5. Patient access and affordability considerations play a crucial role in shaping the market for generic drugs like Primidone.

6. The future market for Primidone will be influenced by factors such as technological innovations, changing treatment paradigms, and potential global market expansion.

FAQs

1. Q: How often do pharmaceutical companies typically adjust their drug prices? A: Pharmaceutical companies often review and adjust their drug prices annually, although the frequency can vary depending on market conditions, competition, and regulatory factors.

2. Q: What impact does the entry of new generic competitors have on drug pricing? A: The entry of new generic competitors typically leads to price erosion, with prices often decreasing by 3-5% annually in competitive generic markets.

3. Q: How do patient assistance programs affect drug pricing strategies? A: Patient assistance programs can help maintain demand for a drug by improving affordability, potentially allowing companies to maintain higher list prices while ensuring patient access.

4. Q: What role does artificial intelligence play in pharmaceutical pricing strategies? A: AI is increasingly being used to optimize pricing strategies, analyze market trends, and improve supply chain efficiency, potentially leading to more dynamic and data-driven pricing models.

5. Q: How might future advancements in epilepsy treatment affect the market for Primidone? A: Future advancements could potentially reduce demand for current anticonvulsants like Primidone if more effective or better-tolerated treatments become available. However, Primidone may remain an important option for certain patients due to its established efficacy and safety profile.

Sources cited: [2] https://www.drugpatentwatch.com/p/drug-price/ndc/51991-0065 [4] https://www.drugpatentwatch.com/p/drug-price/ndc/64950-0243 [6] https://www.vizientinc.com/newsroom/news-releases/2024/vizient-projects-drug-price-inflation [7] https://www.zs.com/insights/pharmaceutical-trends-2025-outlook-ai-supplychain-and-beyond [8] https://www.vizientinc.com/newsroom/news-releases/2024/vizient-projects-3-8-drug-price-increase-driven-by-specialty-pharmaceuticals [9] https://fda.report/NDC/0591-5321